Importantly, HCC and CRC cells with a CTNNB1 mutation commonly showed much stronger nuclear β-catenin localization, compared to CRC cells with APC mutations (Supplementary Fig. S8a,b). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.